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of the UGDH gene and may offer new approaches to investigate
its potential alteration in joint diseases, including osteoarthritis
and rheumatoid arthritis.
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Purpose: Kashin-Beck Disease (KBD) is an endemic, chronic,
degenerative osteoarthropathy which affects 2.5 million of 30
million people living in the KBD region of China. The symptoms
include joint pain, stiffness of the joints after getting up in the
morning, disturbances of flexion and extension in the elbows,
enlarged phalangeal joints and limited motion in the middle-
sized and large joints of the body. It manifests as cartilage
degeneration and necrosis, with pathological changes occurring
in growth plate and articular cartilage. At present the etiology
and pathogenesis of KBD is unclear. One of the most popular
hypotheses is that KBD is caused by mycotoxins. The other
etiologies include selenium deficiency in soil and water in KBD
area, nutrition deficiency and virus infection etc. However, all of
the hypotheses lack adequate experimental evidence to support
any particular conclusion. This study investigated the extracellu-
lar matrix metabolism in cartilage and serum levels of IL-1 beta,
TNF-alpha, MMP-1 and CD44 in serum of KBD patients.
Methods: Immunohistochemical analyses of normal and KBD
patient cartilage (16 adults and 4 children and normal age-
matched patient tissue 4 adults and 3 children) was per-
formed using a monoclonal antibody recognising CD44, the
IGD aggrecase-generated neoepitope (monoclonal antibody BC-
13 recognising ... EGE373) and monoclonal antibody 3-B-3(-)
which recognizes thee nonreducing terminal of CS chains in
osteoarthritic cartilage. In addition, the serum levels of soluble
CD44 (sCD44), IL-1 beta, TNF-alpha and MMP-1 were deter-
mined in KBD patients (20 adults and 18 children) and normal
patients (20 adults and 18 children) using a competitive ELISA.
Results: Toluidine Blue and Saffron O staining indicated there
was a proteoglycan loss in both of KBD children and adult carti-
lage. Strong immunohistochemical staining for CD44 occurred in
14 of 16 adult KBD patients with moderate staining present in the
remaining two patients. Similarly, strong CD44 immunostaining
occurred in 3 of the 4 KBD children with moderate staining in the
fourth KBD child. In contrast, weak CD44 immunostaining was
only found in two of the four normal adult cartilage and none of
the three normal child samples. Immunohistochemical staining
with MAb BC-13 and 3-B-3(-) showed an intensive staining in
both of KBD children and adult cartilage when compared with
the normal cartilage samples. Furthermore, statistically signifi-
cant elevated levels of sCD44, IL-1 beta and TNF-alpha were
found in the sera of both adult and child KBD patients when
compared to serum levels of normal adult and child controls.
However, there was no difference in MMP-1 level between KBD
and normal children.
Conclusions: Our results demonstrate that altered IL-1 beta,
TNF-alpha, aggrecan and CD44 metabolism occurs in the
pathogenesis of KBD and there is an increased aggrecanase-
generated proteoglycan loss from KBD adult and children carti-
lage. These primary metabolic changes are a contributing factor
causing pathology in joint formation and instability which in turn
leads to the onset of secondary osteoarthropathy in the major
load-bearing joints of KBD patients.
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Purpose: Joint bleeds occur frequently in patients suffering from
haemophilia or can occur as a consequence of a trauma. It
has been demonstrated that even a limited number of bleeds in
time leads to severe joint damage. With respect to the mech-
anisms of blood induced joint damage, we have demonstrated
that monocytes/macrophages within the mononuclear cell pop-
ulation together with the red blood cells as present in blood
are responsible for the irreversible inhibition of cartilage matrix
synthesis. Small amounts of IL-1 that are produced by activated
monocytes/macrophages increase the production of hydrogen
peroxide (H2O2) by chondrocytes. The hydrogen peroxide reacts
with haemoglobin-derived iron from damaged and phagocytosed
red blood cells, which results in the formation of hydroxyl radicals
in the vicinity of chondrocytes. This leads to chondrocyte apop-
tosis and with that the irreversible inhibition of cartilage matrix
synthesis.
In search of possible interventions to prevent or limit the cartilage
damaging effects of joint bleeds, we tested interleukin-10 (IL-
10) as an inflammation-controlling cytokine on blood-induced
cartilage damage.
Methods: Healthy human articular cartilage tissue explants were
cultured in the presence or absence of 50% v/v blood for 4 days,
followed by a recovery period of 12 days. IL-10 was added in
0.1, 1 or 10 ng/ml. The effect on cartilage matrix proteoglycan
synthesis, -release, and -content were determined.
Results: IL-10 was able to prevent the decrease in proteoglycan
synthesis and the increase in proteoglycan release of cartilage
exposed to blood dose dependently. As a consequence, the
decrease in proteoglycan content after blood exposure could be
prevented dose dependently. With 10 ng/ml IL-10, which is still a
low dose for local therapeutic treatment, at least 50% reduction
in adverse effects was observed.
Conclusions: The present results show that interleukin-10 pre-
vents the direct harmful effects of blood on articular cartilage.
This effect of IL-10, in addition to its anti-inflammatory prop-
erties, may add to prevention of irreversible degenerative joint
damage as a consequence in time of joint haemorrhages. Al-
though treatment studies in addition to prevention studies have
to be performed, IL-10 might be of use for local treatment of joint.
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Purpose: To verify the involvement of proinflammatory cytokines
IL-17, IL-1β and TNF-α in cartilage vascularization on the pro-
duction of vascular endothelial growth factor (VEGF) by chondro-
cytes isolated from patients with osteoarthritis (OA), rheumatoid
arthritis (RA) and patients with femoral neck fracture (FP), and
to evaluate the production of VEGF by chondrocytes freshly iso-
lated from patients with OA, in comparison with chondrocytes
redifferentiating in micromass.
Methods: Chondrocytes isolated from patients with OA were
maintained in monolayer culture for several passages. Chondro-
